MANAGER INSIGHTS

Inside the unicorn factory

Inside the unicorn factory

An in-depth look at how Cambridge Innovation Capital is leveraging its position within the University of Cambridge’s ecosystem to seek out disruptive innovators in technology and life science.

GUEST ARTICLE

Research and development: An investment thesis for UK recovery

Research and development: An investment thesis for UK recovery

By Steve Phillips, CFO, and Somil Goyal, Investment Lead, at GovGrant – The UK has a rich history of scientific discovery and research. Of the top 100 prescription medicines used around the world today, about 25 per cent were discovered in the UK. The country also has recognised expertise in sectors like AI and machine learning developing around leading universities. 

PODCAST

Cebile Capital's Sunaina Sinha on shifts in LP sentiment

Cebile Capital's Sunaina Sinha on shifts in LP sentiment

In this week's podcast, Sunaina Sinha, managing partner at Cebile Capital, discusses the findings of the firm's recent survey of 100 global LPs, including how LPs have shifted their modus operandi in 2020, who the winners are in terms of allocation flow during the pandemic, and the fact that 51 per cent of LPs expect to increase commitments to private equity in 2021.

SPONSORED CONTENT

“A unique moment”: Growth-stage healthcare investor Endeavour Vision on the technologies and trends driving transformation in digital health and medtech

“A unique moment”: Growth-stage healthcare investor Endeavour Vision on the technologies and trends driving transformation in digital health and medtech

Venture capital and growth equity firm Endeavour Vision has a 20-year history of investing in growth-stage medtech and digital health companies in Europe and the US. Here Private Equity Wire asks Bernard Vogel, co-founder and managing partner, and Meret Gaugler (pictured, above-right, with Vogel), head of investment strategy, for their thoughts on the innovations and key drivers that are shaping the sector’s future. 

INTERVIEW

AlpInvest’s Neal Costello on the continued rise of single-asset secondary deals

AlpInvest’s Neal Costello on the continued rise of single-asset secondary deals

In a yet a further sign of continuing maturity in private equity, its secondary market is being driven by GP-led deals, giving rise to a greater proliferation of single asset transactions. And as AlpInvest’s Neal Costello explains, this is presenting wider opportunities for liquidity providers.